Year: 2005
Type: article
Abstract: In May, the Government Reform Committee of the U.S. House of Representatives held a hearing that explored how drugs with serious safety issues can remain so popular for so long. Representative Henry Waxman describes how what was learned illuminated the practices that pharmaceutical manufacturers use to promote their products to physicians.
Source: New England Journal of Medicine
DOI: 10.1056/nejmp058136
Author: Henry A. Waxman
Language: English
Subfield: Issues, ethics and legal aspects
Field: Nursing
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W1994883059
